Pfizer 2013 Annual Report Download - page 57

Download and view the complete annual report

Please find page 57 of the 2013 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 123

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123

Consolidated Statements of Comprehensive Income
Pfizer Inc. and Subsidiary Companies
56
2013 Financial Report
Year Ended December 31,
(MILLIONS) 2013 2012 2011
Net income before allocation to noncontrolling interests $22,072 $14,598 $10,049
Foreign currency translation adjustments $(535)$(811)$ 796
Reclassification adjustments(a) 144 (207)(127)
(391)(1,018)669
Unrealized holding gains/(losses) on derivative financial instruments 488 745 (726)
Reclassification adjustments for realized (gains)/losses(b) (94)(616)537
394 129 (189)
Unrealized holding gains on available-for-sale securities 151 74 81
Reclassification adjustments for realized (gains)/losses(b) (237)356 (283)
(86)430 (202)
Benefit plans: actuarial gains/(losses), net 3,714 (2,136)(2,246)
Reclassification adjustments related to amortization(c) 581 473 284
Reclassification adjustments related to settlements, net(c) 175 221 140
Other 48 22 (98)
4,518 (1,420)(1,920)
Benefit plans: prior service credits and other 151 25 106
Reclassification adjustments related to amortization(c) (58)(69)(69)
Reclassification adjustments related to curtailments, net(c) 1(130)(91)
Other (8) (3) 3
86 (177)(51)
Other comprehensive income/(loss), before tax 4,521 (2,056)(1,693)
Tax provision/(benefit) on other comprehensive income/(loss)(d) 1,928 (225)(959)
Other comprehensive income/(loss) before allocation to noncontrolling interests $2,593 $(1,831)$ (734)
Comprehensive income before allocation to noncontrolling interests $24,665 $12,767 $9,315
Less: Comprehensive income/(loss) attributable to noncontrolling interests 721 (5)
Comprehensive income attributable to Pfizer Inc. $24,658 $12,746 $9,320
(a) Reclassified into Gain on disposal of discontinued operations—net of tax in the consolidated statements of income.
(b) Reclassified into Other (income)/deductions—net in the consolidated statements of income.
(c) Generally reclassified, as part of net periodic pension cost, into Cost of sales, Selling, informational and administrative expenses, and/or Research and
development expenses, as appropriate, in the consolidated statements of income. For additional information, see Note 11. Pension and Postretirement Benefit
Plans and Defined Contribution Plans.
(d) See Note 5E. Tax Matters: Taxes on Items of Other Comprehensive Income/(Loss).
See Notes to Consolidated Financial Statements, which are an integral part of these statements.